Skip to main content
. Author manuscript; available in PMC: 2014 Mar 22.
Published in final edited form as: Clin Gastroenterol Hepatol. 2008 Apr;6(4):451–458. doi: 10.1016/j.cgh.2008.02.011

Figure 2.

Figure 2

Risk estimates for lymphoma sub-types associated with HCV by study. SLL/CLL, small-cell lymphocytic lymphoma/chronic lymphocytic leukemia. (1) Heterogeneity test: χ2 = 11.69; df = 6; P = .07. (2) Heterogeneity test: χ2 = 0.90; df = 3; P = .83. (3) Heterogeneity test: χ2 = 8.96; df = 6; P = .03. (4) Heterogeneity test: χ2 = 4.80; df = 6; P = .31. (5) Heterogeneity test: χ2 = 7.79; df = 4; P = .10. †OR and 95% CI obtained from the polytomous unconditional logistic regression using a joint fixed-effects model adjusted for age, sex, race, and study center.